US Patent Issued to Helsinn Healthcare, Anacardio on June 9 for "Piperidine urea derivatives for use as inotropic agents" (Italian, Swedish, Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,941, issued on June 9, was assigned to Helsinn Healthcare SA (Lugano/Pazzallo, Switzerland) and Anacardio AB (Solna, Sweden).

"Piperidine urea derivatives for use as inotropic agents" was invented by Lars Lund (Stockholm), Alberto Bernareggi (Cernobbio, Italy), Emanuela Lovati (Mendrisio, Switzerland), Claudio Giuliano (Como, Italy) and Claudio Pietra (San Martino Siccomario, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention concerns the use of compounds represented by formula (I)as inotropic agents. The compounds of formula (I), which include, as preferred, 1-[(1S)-1-(2,3-dichloro-4-methoxyphenyl)ethyl]-3-methyl-3-[(4R)-1-methyl-3,3...